Enhanced Efflux Pump Expression in Candida Mutants Results in Decreased Manogepix Susceptibility

Sean D Liston1, Luke Whitesell1, Mili Kapoor2

  • 1Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Insights

Two efflux-mediated mechanisms confer reduced susceptibility to the antifungal manogepix in Candida pathogens. These involve specific gene mutations and transporter activations in Candida albicans and Candida parapsilosis.

Area of Science:

  • Mycology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Manogepix is a broad-spectrum antifungal agent targeting glycosylphosphatidylinositol (GPI) anchor biosynthesis.
  • Understanding resistance mechanisms is crucial for effective antifungal therapy.

Purpose of the Study:

  • To characterize efflux-mediated resistance mechanisms to manogepix in fungal pathogens.
  • To identify genetic alterations conferring reduced manogepix susceptibility in Candida albicans and Candida parapsilosis.

Main Methods:

  • Whole-genome sequencing was employed to identify genetic changes.
  • Gene expression analysis of transporter genes was performed.

Main Results:

  • In Candida albicans, a ZCF29 transcription factor mutation activated CDR11 and SNQ2 transporter genes.
  • In Candida parapsilosis, a mitochondrial deletion activated the MDR1 transporter gene, leading to decreased manogepix susceptibility.

Conclusions:

  • Efflux pumps play a significant role in manogepix resistance in Candida species.
  • Distinct genetic mechanisms drive resistance in different Candida pathogens, highlighting the need for tailored therapeutic strategies.